Cargando…
Efficacy and safety of Lianhua Qingwen combined with conventional antiviral Western Medicine in the treatment of coronavirus disease (covid-19) in 2019: Protocol for a systematic review and meta-analysis
BACKGROUND: The novel coronavirus pneumonia (COVID-19) has spread to >200 countries and regions. There is no effective antiviral drug for COVID-19. Traditional Chinese medicine, such as Lianhua Qingwen, has achieved some curative effect in many countries, but its effect is not clear. We aim to as...
Autores principales: | Zhang, Xiaolin, Cao, Di, Liu, Junnan, Zhang, Qi, Liu, Mingjun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387000/ https://www.ncbi.nlm.nih.gov/pubmed/32791754 http://dx.doi.org/10.1097/MD.0000000000021404 |
Ejemplares similares
-
An umbrella review of Lianhua Qingwen combined with Western medicine for the treatment of coronavirus disease 2019
por: Yang, Kelu, et al.
Publicado: (2022) -
Meta-analysis on the effect of combining Lianhua Qingwen with Western medicine to treat coronavirus disease 2019
por: Wang, Deng-chao, et al.
Publicado: (2022) -
Lianhua Qingwen prescription for Coronavirus disease 2019 (COVID-19) treatment: Advances and prospects
por: Li, Liu-Cheng, et al.
Publicado: (2020) -
A meta-analysis for Lianhua Qingwen on the treatment of Coronavirus disease 2019 (COVID-19)
por: Zhuang, Jieqin, et al.
Publicado: (2021) -
Efficacy and Safety of Chinese Medicine Lianhua Qingwen for Treating COVID-19: An Updated meta-Analysis
por: Li, Yapeng, et al.
Publicado: (2022)